Lasa Supergenerics Faces Operational Halt, Rs 38.11 Crore GST Demands

Lasa Supergenerics Ltd reported a net loss of Rs 3.58 crore for the quarter ended June 30, 2026. This marks a significant improvement from the Rs 21.12 crore net loss recorded in the same quarter last year (June 30, 2025). However, revenue from operations stood at Rs 1.23 crore, a sharp decline from Rs 20.01 crore in the prior-year period.

Reader Takeaway: Narrowed loss improves sentiment, but halted operations and GST risks loom large.

What just happened

Lasa Supergenerics' Q1 FY27 results reveal a stark operational reality. The company's revenue from operations has plummeted to Rs 1.23 crore from Rs 20.01 crore year-on-year. While the net loss has narrowed to Rs 3.58 crore from Rs 21.12 crore, this is primarily due to reduced expenses rather than operational recovery.

The core manufacturing facility, the Mother Unit at Lote Parshuram, has been non-operational since a fire incident on May 18, 2025. The company is unable to assess the damage due to an unrecognized labour union strike obstructing access.

Why this matters

The continued operational stoppage poses a significant threat to the company's future. Without its primary manufacturing unit, Lasa Supergenerics is unable to generate substantial revenue. The company is exploring contract manufacturing or leasing as alternatives, but these are contingent on regulatory approvals.

Furthermore, the company faces substantial financial risks, including GST demands totaling Rs 38.11 crore. These demands are being contested, and the company has not made any provision, classifying them as contingent liabilities.

The backstory

Lasa Supergenerics has been grappling with operational issues since the fire incident. The lack of insurance coverage for the affected assets exacerbates the situation. The auditor's report highlights multiple concerns, including the inability to obtain bank balance confirmations for dormant accounts and the suspension of revenue recognition under force majeure for certain invoices.

What changes now

Management is actively seeking solutions, including contract manufacturing or facility leasing, to resume operations. However, these steps are subject to obtaining necessary statutory and regulatory approvals.

The company's financial health remains precarious, with the 'going concern' status facing significant uncertainty due to the ongoing operational and financial challenges.

Risks to watch

Key risks include the prolonged non-operational status of the manufacturing facility, the outcome of the Rs 38.11 crore GST demands, and the potential impact of the 'going concern' uncertainty on future funding and operations.

Auditor Observations

Gupta Rustagi & Co., the statutory auditor, has raised concerns about the GST demands and the inability to obtain confirmations for dormant bank accounts and fixed deposits. Revenue recognition for certain invoices has also been suspended due to force majeure.

Context metrics (time-bound)

For the quarter ended June 30, 2026:

• Revenue from Operations: Rs 1.23 crore
• Net Profit/(Loss): (Rs 3.58 crore)
• EPS (Basic): (0.71)

Compared to the quarter ended June 30, 2025:

• Revenue from Operations: Rs 20.01 crore
• Net Profit/(Loss): (Rs 21.12 crore)
• EPS (Basic): (4.22)

What to track next

Investors should closely monitor developments regarding the resumption of manufacturing operations, the resolution of GST-related litigation, and any further updates on the company's going concern status.